17 Nov 2025Open access5cites
African Natural Products Database (ANPDB): A resource for exploring the therapeutic potential of natural compounds from AfricaPublisher siteNucleic Acids Research, Molecular spectroscopy and chirality
UniversitiesConrad V. Simoben
Active, last published 2026
In computational drug discovery methods
Conrad V.
Simoben
Scholar“Research focused on Computational Drug Discovery Methods and adjacent fields.”
University of Toronto
Claim Your Profile19
H-index
1.3k
Citations
Conrad has not officially claimed their profile. If you are Conrad, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
onrad V. Simoben is a researcher working on Computational Drug Discovery Methods. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Conrad's work has been cited 1,268 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Computational Drug Discovery Methods×25Ethnobotanical and Medicinal Plants Studies×11Microbial Natural Products and Biosynthesis×10Natural product bioactivities and synthesis×7Histone Deacetylase Inhibitors Research×7
04 · Where I am
Affiliations
Affiliation on published researchUniversity of TorontoDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
7 works24 Oct 2025Open access1cites
Iboga‐Indole Alkaloids as Potential Plasmodial Inhibitors: Identification, Biosynthesis, and Molecular Docking StudiesPublisher siteChemistry & Biodiversity, Alkaloids: synthesis and pharmacology
16 Oct 2025Open access1cites
Global innovative perspectives and trends on digital health and patient safety: highlights from the #DHPSP2024 networking eventPublisher siteExploration of Digital Health Technologies, Artificial Intelligence in Healthcare and Education
26 Mar 20258cites
Natural Products in Cyperus Species (Cyperaceae): Phytochemistry, Pharmacological Activities, and BiosynthesisPublisher siteChemistry & Biodiversity, Botany, Ecology, and Taxonomy Studies
23 Feb 2025Open access1cites
An evaluation of spirooxindoles as blocking agents of SARS-CoV-2 spike/ACE2 interaction: synthesis, biological evaluation and computational analysisPublisher siteMedicinal Chemistry Research, Computational Drug Discovery Methods
21 Jun 20246cites
Computational discovery of dual potential inhibitors of SARS‐CoV‐2 spike/ACE2 and Mpro: 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamicsPublisher siteEuropean Biophysics Journal, Computational Drug Discovery Methods
23 Mar 2024Open access7cites
Investigation of some plant stilbenoids and their fragments for the identification of inhibitors of SARS-CoV-2 viral spike/ACE2 protein bindingPublisher siteThe Microbe, Computational Drug Discovery Methods
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Conrad?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you